Company Profile

FORTIS MALAR HOSPITALS LTD.

NSE : NABSE : 523696ISIN CODE : INE842B01015Industry : Hospital & Healthcare ServicesHouse : Fortis
BSE60.50-0.45 (-0.74 % )
PREV CLOSE (Rs.) 60.95
OPEN PRICE (Rs.) 59.75
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2827
TODAY'S LOW / HIGH (Rs.)59.75 61.00
52 WK LOW / HIGH (Rs.) 40 64.7
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 1.70463
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) -8.10
ROCE (%) -4.39
Incorporation Year : 1989

Management Info :

Daljit Singh - Chairman - Managing Director

Registered Office :

Address : Fortis Hospital,Sector 62,Phase - Viii,
Mohali,
Punjab-160062

Phone : 0172-5096001

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE
NEWS More
31Mar03-31-2021$ Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Announcement under Regulati
This is to inform you that Company has received a resignation letter from Mayank Jain, Company Secretary cum Compliance Officer with effect from March 31, 2021 (Close of business hours) due to his personal reason. You are requested to take the above information on records.
This is to inform you that Company has received a resignation l..
24Mar03-24-2021$Fortis Malar Hospitals informs about application for reclassification of promoter Fortis Malar Hospitals infor

Fortis Malar Hospitals has informed that in continuation of letter no: FMHL/SEC/SEP19 dated September 11, 2019, FMHL/SEC/FEB20 dated February 11, 2020, FMHL/SEC/Mar20 dated March 3, 2020 and FMHL/SEC/FEBRUARY21 dated February 22, 2021, SEBI has granted exemption vide letter no: SEBI/HO/CFD/CMD1/OW/2021/2489/1/M dated March 23, 2021, from applicability of the procedural requirements specified at regulation 31A(3)(a)(i) and 31A(8)(a) & (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations). Further, the Company is advised to ensure compliance with all other provisions of regulation 31 A of the LODR Regulations for reclassification of promoters.

The above information is a part of company’s filings submitted to BSE.

Fortis Malar Hospitals has informed that in continuation of let..
11Mar03-11-2021$Fortis Malar Hospitals informs about appointment of director Fortis Malar Hospitals infor
Fortis Malar Hospitals has informed that appointment of Shailaja Chandra (DIN: 03320688) as an Independent Director of the Company has been approved with requisite majority by way of postal ballot as well as through e-voting. It has enclosed result of postal ballot in prescribed format along with Scrutinizers Report.

The above information is a part of company’s filings submitted to BSE.

Fortis Malar Hospitals has informed that appointment of Shailaj..
01Feb02-01-2021$Appointment of Director Appointment of Director
Inter alia, Board of Directors of the Company at its meeting held today i.e. February 1, 2021, considered and recommended to the Shareholders of the Company, the candidature of Ms. Shailaja Chandra (DIN:03320688 and aged 76 years) to be appointed as an Independent Director of the Company for a period of five years, not liable to retire by rotation.
Inter alia, Board of Directors of the Company at its meeting h..
19Jan01-19-2021$ Announcement under Regulation 30 (LODR)-Resignation of Director Announcement under Regulati
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Para A of Part A of Schedule III to the said Regulations, we hereby inform that Mr. Murari Pejavar, has tendered resignation from the position of the Independent Director of the Company with effect from January 18, 2021. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 are enclosed. Further, there is no other material reason for his resignation other than stated above. A copy of his resignation letter received, is enclosed. You are requested to take the above on your record.
Pursuant to Regulation 30 of the Securities and Exchange Board..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit-9.38-90.5700000000001
Gross Profit -13 -121.56
Operating Profit 23.7881.8299999999999
Net Sales 228.381118.72
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Kovai Medical Center (BSE)
 1134.65 (2.02%)
M.Cap ( in Cr)
1241.56
Shalby (BSE)
 113.10 (7.25%)
M.Cap ( in Cr)
1221.59
Dr Agarwals Eye Hsp (BSE)
 330.00 (1.55%)
M.Cap ( in Cr)
155.10
Dr Lalchandani Labs (BSE)
 15.80 (12.06%)
M.Cap ( in Cr)
6.85
Indraprastha Medical (BSE)
 55.90 (1.73%)
M.Cap ( in Cr)
512.45
Shareholding Pattern More
PROMOTERS 62.71 %
NON-INSTITUTION 37.22 %
MUTUAL FUNDS/UTI 0.07 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes